Sarepta Therapeutics (SRPT) Debt Ratio (2010 - 2026)

Sarepta Therapeutics' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.26 for Q1 2026.

• In Q1 2026, Debt Ratio fell 19.73% year-over-year to 0.26; the TTM figure through Mar 2026 stood at 0.26 (down 19.73% YoY), while the FY2025 annual figure was 0.25, down 13.75% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.26, up from 0.25 in the prior quarter.
• The five-year high for Debt Ratio was 0.49 in Q4 2022, with the low at 0.25 in Q4 2025.
• The 5-year median for Debt Ratio is 0.37 (2022), against an average of 0.36.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio surged 175.69% in 2022, then tumbled 30.28% in 2024.
• Sarepta Therapeutics' Debt Ratio stood at 0.49 in 2022, then declined by 16.63% to 0.41 in 2023, then plunged by 30.28% to 0.29 in 2024, then slipped by 13.75% to 0.25 in 2025, then advanced by 6.54% to 0.26 in 2026.
• Business Quant data shows SRPT's Debt Ratio at 0.26 in Q1 2026, 0.25 in Q4 2025, and 0.31 in Q3 2025.